Skip to content

Comparing the efficiency of two electrical nerve stimulation techniques in improving impairments, activities of daily living, and quality of life among female subjects with overactive bladder syndrome.

Transcutaneous posterior Tibial nerve stimulation a novel treatment for Refractory overactive bladder. - NILL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099269
Enrollment
40
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

Intervention1: Transcutaneous Electrical Nerve Stimulation for Transcutaneous Tibial Nerve Stimulation: Intervention in the control group was TTNS with Transcutaneous Electrical Nerve Stimulation (TEN
the commonly used range was 30 to 70 mA. (24) Usually we increased the intensity gradually and tried to reach a level at which we elicited a motor response of great toe extension. The therapy consists

Sponsors

Krishna Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of the study were people suffering from overactive bladder disorder (OABD), and the population included in our study was adult females.

Exclusion criteria

Exclusion criteria: The subjects of OABD who had undergone any surgical procedure for the same problem, had metal implants in the tibia and foot, lack of sensation in the foot, or had any other bladder disorder were excluded from the study process.

Design outcomes

Primary

MeasureTime frame
International Consultation on Incontinence Questionnaire for Overactive Bladder (ICIQ-OAB), and International Consultation on Incontinence Questionnaire for Overactive Bladder Quality of life (ICIQ-OAB qol)Timepoint: baseline and 4 weeks

Secondary

MeasureTime frame
Age, height, weight, BMI, Duration of DiseaseTimepoint: Baseline

Countries

India

Contacts

Public ContactDr Nirmala A Papalkar

Krishna Institute of Medical Sciences

nirmala.amber@gmail.com9701555605

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026